Radio and PodcastRadio and PodcastLive Radio & Podcasts
FDA 483, Mapp & News artwork
Science & Medicine

FDA 483, Mapp & News

Good Pharma Manufacturing : GMP FDA GDP 483 source. by Alan McPeck

Sep 17, 201803:50Science & Medicine

Valsartin API NDEA / NDMA contamination, MAPP 5014.1 Risk Based Site Selection Model. OSS 483 Inspection. Good Pharma Manufacturing covers many pharmaceutical topics from cGMP's, GDP's, compliance, training, drug recalls...

About This Episode

FDA 483, Mapp & News is an episode from Good Pharma Manufacturing : GMP FDA GDP 483 source. by Alan McPeck. Valsartin API NDEA / NDMA contamination, MAPP 5014.1 Risk Based Site Selection Model. OSS 483 Inspection. Good Pharma Manufacturing...

Podcast

This episode belongs to Good Pharma Manufacturing : GMP FDA GDP 483 source..

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Sep 17, 2018, 03:50 long, audio available.

Related Episodes

Continue listening to more episodes from Good Pharma Manufacturing : GMP FDA GDP 483 source..

Weekly 483 update

Aug 22, 2018 - 06:23

Good Pharma Manufacturing covers many pharmaceutical topics from cGMP's, GDP's, compliance, training, dru...

Mise N Place - weekly 483

Apr 9, 2018 - 20:31

Everything in its place and weekly 483 Good Pharma Manufacturing covers many topics from cGMP's, GDP's, c...

10 causes of human errors

Apr 3, 2018 - 04:34

Human errors in the work place cause many issues. Here is my top 10 list of causes. Good Pharma Manufactu...